Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000533337 | SCV000651424 | likely benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2023-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571470 | SCV000674928 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003980003 | SCV004797522 | likely benign | SDHA-related condition | 2023-03-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |